GHO Capital and Excellere Partners Invest in Biocare Medical
December 9, 2021
London-based GHO Capital has invested in Biocare Medical, a California-headquartered developer of immunohistochemistry reagents and diagnostic instrumentation, alongside existing investor Excellere Partners. The capital will be used to accelerate R&D, expand the instrument offering, and support international expansion to capture growing demand for oncology diagnostics.
- Buyers
- GHO Capital Partners LLP, Excellere Partners
- Targets
- Biocare Medical
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Biocare Medical Acquires Empire Genomics
November 23, 2022
Biotechnology
Biocare Medical, a GHO Capital-backed provider of automated IHC and FISH instrumentation and reagents, has acquired Empire Genomics, a designer and manufacturer of FISH/CISH probes and molecular biomarkers. The deal expands Biocare's molecular portfolio (bringing over one million biomarkers) and adds rapid biomarker development capabilities to accelerate cancer research and diagnostics.
-
Excellere Partners Invests in Concord Technologies
January 30, 2019
Cloud & SaaS
Denver-based private equity firm Excellere Partners has made a strategic growth investment in Concord Technologies, a Seattle-based provider of secure, cloud-based healthcare interoperability, document automation and AI-powered workflow solutions. The capital will support Concord’s scaling efforts and product/capability expansion as the company continues to serve over 1,500 customers with its NEXTSTEP platform and other interoperability offerings.
-
GHO Capital Invests in FairJourney Biologics
January 30, 2020
Biotechnology
London-based private equity firm GHO Capital has made an investment in FairJourney Biologics, a Porto-headquartered antibody discovery and biologics CRO, partnering with founders Antonio Parada and Maria Gonzalez-Pajuelo to accelerate global growth. The capital will support expansion of footprint, capacity and service capabilities through both organic and inorganic initiatives as FairJourney scales to meet rising demand from biopharma clients.
-
GHO Capital Acquires Velocity Clinical Research
July 15, 2021
Healthcare Services
Global Healthcare Opportunities (GHO) has acquired Durham-based Velocity Clinical Research from NaviMed Capital and other investors. GHO intends to support Velocity’s roll-up strategy of clinical trial sites, expand its integrated site model (including investment in technology and decentralized trial capabilities) and pursue further geographic expansion, including into Europe.
-
GHO Capital Partners Acquires Majority Stake in Sapio Sciences
December 1, 2022
Cloud & SaaS
London-based healthcare investor GHO Capital Partners has acquired a majority stake in Sapio Sciences, a US-based lab informatics platform providing LIMS, ELN and scientific data management solutions. GHO will support Sapio's international expansion (especially into Europe), operational improvements and growth through M&A to scale the company's SaaS offering for biopharma, CROs and diagnostic labs.
-
GHO Capital Recapitalizes ClearView Healthcare Partners
September 1, 2021
Healthcare Services
GHO Capital Partners LLP has acquired a majority ownership position in ClearView Healthcare Partners in a majority recapitalisation from RLH Equity Partners and ClearView management. The investment will support ClearView’s international expansion (particularly into Europe) and the broadening of its life-sciences consulting capabilities, including data analytics and pricing & market access services.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.